Efficacy and Safety Study of TOOKAD® Soluble for Localised Prostate Cancer Compared to Active Surveillance.
NCT01310894
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
413
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
TOOKAD® Soluble
Sponsor
Steba Biotech S.A.